Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Enterprise Technology
  • Contract Manufacturing
  • R&D 100 Awards

Kodak stock down 30% after pharma deal put on hold

By Chris Newmarker | August 10, 2020

Eastman KodakShares of Eastman Kodak (NYSE: KODK) were down more than 30% near the close of trading today after a tweet from the U.S. International Development Finance Corp. said a $765 million loan for domestic pharmaceutical manufacturing is on hold. 

The Aug. 7 tweet said: “On July 28, we signed a Letter of Interest with Eastman Kodak. Recent allegations of wrongdoing raise serious concerns. We will not proceed any further unless these allegations are cleared.”

The agency added: “We remain committed to working together with other government agencies to address critical shortfalls in America’s pharmaceutical supply chain.”

The loan is supposed to support the retooling of Kodak’s existing facilities in Rochester, N.Y., and St. Paul, Minn., incorporating continuous manufacturing and advanced technology so that a new Kodak Pharmaceuticals can produce critical pharma ingredients inside the U.S. — a major Trump administration goal.

Kodak has faced scrutiny over how its executives handled stock transactions around the announcement. House Democrats are launching an investigation — asking not only about the transactions but also how a company focused on photography was able to win Trump administration support to manufacture drugs.

Kodak has created a special committee of independent directors that is retaining Akin Gump Strauss Hauer & Feld to conduct an internal review.

Tell Us What You Think! Cancel reply

Related Articles Read More >

Biden
Biden leaning on Defense Production Act to bolster COVID-19 vaccine supplies
Amazon offers to help Biden administration with vaccine distribution
Pfizer-BioNTech vaccine
U.S. government stockpile of COVID-19 vaccines already drained
Dr. David Kessler
Former FDA commissioner Kessler to help lead Biden’s COVID-19 response

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup

R&D Twitter

Tweets by @RandDWorld
Pharmaceutical Processing World
  • Enews Signup
  • Contact Us
  • About Us
  • R&D World
  • DeviceTalks
  • Drug Discovery & Development
  • Drug Delivery Business News
  • MassDevice
  • Medical Design Sourcing

Copyright © 2021 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Enterprise Technology
  • Contract Manufacturing
  • R&D 100 Awards